AbbVie is buying a biotech working on an experimental eczema drug for $10.9 billion

SA Asks: After a major sell-off, what's next for Accenture?

2026/06/22

Invesco S&P Emerging Markets Momentum ETF declares distribution

2026/06/22

Oil falls as US waives Iranian sanctions and Nasdaq tumbles

2026/06/22

Salesforce’s stock extends record losing streak. Can the company disrupt itself?

2026/06/22